Rafarma Pharmaceuticals, Inc. (RAFA) manufactures and markets pharmaceutical goods. It produces different innovative medical drugs in all delivery methods for various pharmacological groups.
This is one penny stock to keep an eye on; year to date downward stock chart trending is starting to head back up. Late last year press included, “Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs”, a joint project for the production of the “popular platinum-based chemotherapy drugs”. And, “RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research”, the negotiation of developing and implementing projects related to nuclear medicine technologies, radiopharmaceuticals, radiotherapy, and other projects in related industries.
Visit the website to learn more – www.noyarp.com.